John E. Bailey SEC EDGAR Filings (CIK 0001806147)

SEC EDGAR filings, ownership reports, and insider transactions for John E. Bailey.

Business address
C/O G1 Therapeutics, Inc., 700 Park Offices Drive, Suite 200, Research Triangle Park, NC, 27709
Top holdings (ownership)
GTHX
Get insider transactions for this reporting owner
John E. Bailey has filed 15 SEC EDGAR filings since 13 Mar 2020

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 4 18 Sep 2024 18 Sep 2024 001-38096
4 Open Document Open Filing PRIMARY DOCUMENT 08 Jul 2024 05 Jul 2024 001-38096
4 Open Document Open Filing PRIMARY DOCUMENT 03 Jul 2024 01 Jul 2024 001-38096
4 Open Document Open Filing PRIMARY DOCUMENT 15 May 2024 13 May 2024 001-38096
4 Open Document Open Filing PRIMARY DOCUMENT 08 Jan 2024 03 Jan 2024 001-38096
4 Open Document Open Filing PRIMARY DOCUMENT 02 Jan 2024 02 Jan 2024 001-38096
4 Open Document Open Filing PRIMARY DOCUMENT 07 Jul 2023 05 Jul 2023 001-38096
4 Open Document Open Filing PRIMARY DOCUMENT 12 May 2023 10 May 2023 001-38096
4 Open Document Open Filing PRIMARY DOCUMENT 05 Jan 2023 03 Jan 2023 001-38096
4 Open Document Open Filing PRIMARY DOCUMENT 05 Jan 2022 03 Jan 2022 001-38096
4 Open Document Open Filing FORM 4 SUBMISSION 05 Jan 2021 01 Jan 2021 001-38096
4 Open Document Open Filing PRIMARY DOCUMENT 13 Nov 2020 10 Nov 2020 001-38096
4 Open Document Open Filing FORM 4 SUBMISSION 12 Jun 2020 11 Jun 2020 001-38096
4 Open Document Open Filing PRIMARY DOCUMENT 13 Mar 2020 12 Mar 2020 001-38096
3 Open Document Open Filing PRIMARY DOCUMENT 13 Mar 2020 12 Mar 2020 001-38096